Q1 Seasonality In The Pharma/Biotech Space: What It Is, Why It Happens And Who Is Affected


Biotech investors may have noticed that the first quarter of the year is a bit sluggish for drug sales . They aren't imagining things, according to Bernstein analyst Aaron Gal .



from Biotech News